Abraham Heifets
Co-Founder & CEOAtomwiseVenkat Mattela
Founder and CEOCeremorphicPetrina Kamya
Global Head of AI Platforms, VP Insilico Medicine PresidentInsilico Medicine Canada Inc.Alex Gaither
Vice President and Head of OncologyExscientiaElena Diaz Cecilia
Senior Director, External InnovationJanssen R&DStephen MacKinnon
Vice President of Digital ChemistryRecursion PharmaDaniel Jamieson
CEOBiorelateAndreas Holm Mattsson
Chief AI Officer & FounderEVAXIONByungchan Kim
Executive Director in Drug DiscoveryXTALPIAri Allyn-Feuer
Director AI ProductGSKDane Corneil
AI Lead for Target-IDBenevolentaiClement Charelain
Head Human Genetics and GenomicsSanofiClaire Zhao
Associate Director of AI/ML & Quantitative and Digital SciencesPFIZERNeil Inala
Chief Executive OfficerNobias TherapeuticsNick Nystrom
Chief Technology OfficerPeptilogicsDiana Miszczuk
Director External Partnerships, Digital & Research IntelligenceNOVO NORDISKAaron Mackey
VP Head of AI and MLSonataLingling Shen
Associate Director Discovery SciencesNOVARTISChris Tame
VP Head of Drug DiscoveryCELERIS THERAPEUTICSEd Addison
Executive Chairman & Acting CEOCLOUD PHARMACEUTICALSMartin Gershon
Managing Partner & CIOEndeavor Life Sciences Venture FundsDr. Martin Gershon is the Managing Partner and CIO of Endeavor Life Sciences Venture Funds ($1B AUM) and Venture Studio ($570M AUM). He has been featured on CNBC and in numerous conferences and publications as one of the leading healthcare investors, strategists, futurists and entrepreneurs. Over the past 23 years he raised over $1B, personally founded/exited 6 startups, lead Endeavor Funds to 69 investments, and has served as Senior Strategic Healthcare Advisor for Fortune 500 Companies including McKinsey, Goldman Sachs, Bain Capital, Fidelity, TPG, BlackRock, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis, Rockefeller Foundation, WHO, and the Bill and Melinda Gates Foundation.
Dr. Gershon has been honored by Standard and Poor’s as a designated top 100 “Healthcare Industry Leader” and has developed Endeavor into a thriving ecosystem of partnerships with BioPharma, Medtech, Digital Health, and Big Tech companies, world class CEO entrepreneurs, start-up accelerators, and prominent Ivy League universities, medical centers, and business schools like Harvard, Columbia, MIT, NYU, McGill and Johns Hopkins.
Dr. Gershon is committed to helping emerging CEO/Founder Entrepreneurs and serves as a Lead Mentor for Techstars and as a member of the Techstars Start-Up Selection Committee, Executive-in-Residence and Advisor for Matter Health, Mentor for NYU Berkley Center for Entrepreneurship, Selection Committee Advisor for Ben Franklin Technology Partners, Investor for PlugNPlay Tech Center, Advisory Board Member McGill Innovation Fund, and Investor and Advisor for MassChallenge.
Dr. Gershon is a former Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Harvard and Columbia trained neuroscientist, oncologist, immunologist, FDA attorney, Lecturer and Professor at Harvard, MIT, Johns Hopkins, Oxford, Columbia, Chief of Innovation and Investment at McGill, and a contributing author of healthcare entrepreneurship and finance at Fast Company.
Andrew Hedin
PartnerBessemer Venture PartnersLiz Schwarzbach
Chief Business OfficerBigHat BiosciencesColm O'Dushlaine
Head of Statistical GeneticsINSITROSimon Beaulah
SVP Precision Drug RepositioningPRECISIONLIFEArvind Rao
Associate Professor Computational Medicine & BioinformaticsUniversity of MichiganGary An
Professor of Surgery and Board Member Complexity in Acute IllnessUniversity of VermontAlla Bushoy
Engineering Team LeadAstraZenecaMax Liu
Senior Software Engineer - Early ScienceAstraZenecaJian Fang
Senior Expert II Data Science Discovery SciencesNOVARTISHunter Elliot
Principal Machine Learning ScientistBigHat BiosciencesZachary Webel
Data Scientist and Applied MathematicianFDASourav Bandyopadhyay
Chief Technology OfficerRezo TherapeuticsMatthias Alder
Chief Executive OfficerGain TherapeuticsLu Zhang
Founder & Managing PartnerFusion FundSham Dholakia
Chief Medical OfficerGen13 Life Science